News
JCVI statement on the shingles (herpes zoster) vaccination programme
Source: DHSC/ Gov.uk 13.11.24 Advice The Joint Committee on Vaccination and Immunisation (JCVI) previously recommended that the universal shingles vaccination programme should be updated to offer 2 doses of Shingrix®...
How increased staff costs will affect your practice, and action to take now – By AISMA
Source: Practice Index November 14, 2024 by AISMA in AISMA, General Practice, GP Practice Management Looming staff cost increases are causing sleepless nights for many Practice Managers. James Gransby, Vice Chairman of the Association of Independent Specialist...
Transforming Controlled Drug Recording in Dispensing Practices!
Controlled Drug Records The original pharmacy CD platform was established in 2013 by PharmData- a team of Pharmacists dedicated to producing bespoke software for pharmacies. Collaborating with Dispex, PharmData customised...
Class 4 Medicines Defect Information: Takeda UK Limited, Entyvio 108mg solution for injection in pre-filled syringe, EL(24)A/55
Source: MHRA/ Gov.uk 18.11.24 Takeda UK Limited has informed the MHRA that there is an error in the Patient Information Leaflet for specified batches of Entyvio 108mg pre-filled syringes. DMRC...
NEWS ALERT: Drug Supply Update-15th November
Drug Supply Page Dispex provides primary care focused updates on drug supply issues. Data is taken from the SPS website on a weekly basis. Dispex members can login here to see the updated...
Consultation on Medical Devices Regulations: Routes to market and in vitro diagnostic devices
Source: MHRA / Gov.uk 14.11.24 The MHRA is inviting members of the public to provide their views on proposed changes to the regulatory framework for medical devices. This consultation closes...
Company led medicines recall: Leeds Trading Company LTC Ltd T/A LTC Healthcare, EXS Delay Spray Plus, CLMR(24)A/01
Source: MHRA/Gov.uk 13.11.24 LTC Healthcare has informed the MHRA that they have been selling a medicinal product containing lidocaine without authorisation from the MHRA. CLMR Number CLMR (24)A/01 DMRC Reference...
Class 4 Medicines Defect Information: Viatris UK Healthcare Ltd, Omeprazole 40 mg Powder for solution for infusion, EL(24)A/54
Source: MHRA/Gov.uk 12.11.24 Generics (U.K.) Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Omeprazole 40 mg Powder for solution for infusion do...
We’ve Listened – join us for a comprehensive tutorial on Endorsing
Given the substantial volume of enquiries we have received from our members regarding endorsing and its intricacies, we’ve developed a focused lunchtime tutorial! Managing endorsements has always been a significant...
The DES Specification Contract- Training Funding!!
Leadership and Management Training Funding The 2024-25 PCN DES contract specification allows for a Leadership and Management payment, but this is now combined into the core PCN Funding. Please click...
NEW: FREE CPD Educational Resources
New Service We are pleased to offer Gazette readers FREE CPD Educational Resources. Our new concise modules outline and reinforce best practices, offering an easy and quick way to enhance...
Class 4 Medicines Defect Information: Ennogen Healthcare Limited, Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion, EL (24)A/53
Source: MHRA /Gov.uk Ennogen Healthcare Limited has identified that action had not been taken to ensure the Patient Reminder Card (PRC) was distributed alongside the packs of product as part...
